Right Ventricular Infarction: Recognition and Haemodynamic Management

Definition and pathophysiology

Right ventricular infarction (RVI) is myocardial necrosis involving the right ventricle, most often occurring in association with an inferior left ventricular infarction. At least minor right ventricular necrosis is found in approximately one-third of patients with inferior infarction. Extensive involvement is less common in patients with inferoposterior left ventricular infarction, while infarction confined predominantly to the right ventricle is rare.

The clinical spectrum extends from limited right ventricular dysfunction to severe right-sided failure and cardiogenic shock. The haemodynamic disturbance results from impaired right ventricular contraction and reduced forward flow through the pulmonary circulation. Consequently, left ventricular filling falls and cardiac output may become markedly depressed. Right-sided filling pressures—including central venous, right atrial, and right ventricular end-diastolic pressures—are elevated, whereas left ventricular filling pressure is usually normal or only modestly increased. Right ventricular systolic and pulse pressures are reduced.

The central management principle is preservation of adequate right ventricular preload while supporting left ventricular performance and systemic circulation. Improvement in left ventricular function also lowers pulmonary arterial and pulmonary capillary wedge pressures, thereby reducing the load faced by the failing right ventricle.

Clinical presentation and symptoms

Clinically important RVI is characterized by manifestations of severe right ventricular failure. Typical findings include:

• Jugular venous distension

• Kussmaul’s sign

• Hepatomegaly

• Hypotension, which may or may not be present

• Markedly reduced cardiac output in severe cases

• Cardiogenic shock in the most advanced presentations

The symptoms of RVI commonly occur in the setting of an inferior myocardial infarction. The available source material emphasizes the haemodynamic and physical manifestations rather than providing a separate catalogue of symptom patterns.

The severity of right ventricular involvement should be considered when inferior infarction is accompanied by disproportionate systemic venous congestion, hypotension, or evidence of low output despite relatively limited elevation of left-sided filling pressure.

Evaluation and physical examination

Initial assessment should establish whether the patient has clinically significant right ventricular failure and whether haemodynamic instability is present.

Physical examination

The examination should specifically assess:

• Jugular venous pressure and the presence of jugular venous distension

• The inspiratory response of the jugular venous pressure, looking for Kussmaul’s sign

• Hepatomegaly as evidence of systemic venous congestion

• Blood pressure and evidence of hypotension

• Clinical evidence of low cardiac output or shock

RVI may produce severe venous congestion even when the left-sided filling pressure is normal or only slightly elevated. This combination—systemic venous hypertension with relatively modest left-sided congestion—is an important clinical clue.

Haemodynamic severity

The presentation may range from mild right ventricular impairment to cardiogenic shock. Patients with hypotension, marked low output, or persistent severe symptoms require close monitoring and consideration of invasive haemodynamic assessment when precise measurements are needed to guide therapy.

Diagnostics

Electrocardiography

Right-sided precordial ECG leads are particularly useful. ST-segment elevation in these leads, especially lead V_R, is frequently observed during the first 24 hours in patients with RVI.

The ECG should therefore include right-sided precordial leads when RVI is suspected in the setting of an inferior infarction. The presence of right-sided ST-segment elevation supports the diagnosis, although the source material does not provide sensitivity, specificity, or threshold criteria.

Echocardiography

Two-dimensional echocardiography helps define the degree of right ventricular dysfunction. It provides a non-invasive assessment of the severity of right ventricular involvement and can support the clinical diagnosis when systemic venous congestion or hypotension is present.

Echocardiography is particularly valuable when the clinical picture is uncertain or when the extent of right ventricular impairment needs to be established during management.

Right-heart catheterization

Right-heart catheterization provides direct measurement of intracardiac pressures and cardiac haemodynamics. It may be useful when:

• The cause of symptoms is uncertain

• Precise filling-pressure measurements are required

• Heart failure is complicated by clinically significant hypotension

• Systemic hypoperfusion or end-organ dysfunction is present

• The patient depends on inotropic infusions

• Severe symptoms persist despite adjustment of recommended therapy

In RVI, catheterization may demonstrate a characteristic haemodynamic pattern resembling constrictive pericarditis. Described features include:

• A steep right atrial “y” descent

• An early diastolic dip followed by a plateau in right ventricular pressure waveforms

The pressure profile typically shows elevated right-sided filling pressures, reduced right ventricular systolic and pulse pressures, and a normal or only slightly raised left ventricular filling pressure. Cardiac output may be substantially reduced.

Right-heart catheterization is not required routinely in every patient. Invasive monitoring should be reserved for circumstances in which haemodynamic definition is clinically necessary. More broadly, pulmonary artery catheter-guided management has not shown a clear morbidity or mortality advantage over careful clinical assessment in advanced heart failure; nevertheless, invasive assessment retains a role in patients with hypotension, systemic hypoperfusion, end-organ dysfunction, or persistent severe symptoms.

Biomarkers and laboratory findings

The source material does not provide specific biomarker or laboratory findings for the diagnosis or management of right ventricular infarction. It emphasizes clinical assessment, ECG, echocardiography, and haemodynamic measurements.

Treatment and management

Immediate management principles

Treatment should address both the infarct-related right ventricular dysfunction and its haemodynamic consequences. The principal therapeutic objectives are:

• Maintain sufficient right ventricular preload.

• Preserve or restore forward flow through the pulmonary circulation.

• Support left ventricular performance.

• Improve systemic perfusion and prevent progression to shock.

• Monitor for deterioration and complications.

Volume expansion

Volume expansion is a central component of treatment. The purpose is to maintain adequate right ventricular preload in the setting of impaired right ventricular contraction.

Volume administration should be guided by the clinical response and, when necessary, by haemodynamic measurements. The source material specifies the principle of volume expansion but does not provide a fluid type, bolus volume, infusion rate, or target filling pressure. Excessive volume administration is not addressed in the supplied material and therefore cannot be defined further here.

Improvement of left ventricular performance

Efforts to improve left ventricular performance form the second major element of management. Enhanced left ventricular function is associated with reduction in pulmonary capillary wedge pressure and pulmonary arterial pressure, thereby reducing the pressure burden transmitted to the right ventricle.

The source material does not specify particular inotropes, vasopressors, or other drug regimens for isolated RVI. In patients with right heart failure requiring intensive care, supportive management may include inotropes, vasopressors, fluid management, and pulmonary arterial hypertension drugs when appropriate, under the direction of physicians with relevant expertise. These measures should be tailored to the causative condition and haemodynamic state.

Management of cardiogenic shock

Patients with RVI and cardiogenic shock require intensive cardiovascular and critical-care support. Management should include treatment of causative factors and supportive measures directed at systemic perfusion and right ventricular function.

Mechanical circulatory support may be considered in selected patients as a bridge to transplantation or recovery. If the required resources are unavailable locally, interhospital transfer should be considered.

Monitoring and level of care

The intensity of monitoring should reflect the severity of haemodynamic compromise and the clinical course. Patients with major complications of myocardial infarction—including cardiogenic shock, refractory arrhythmias, continuous intravenous vasoactive therapy, invasive haemodynamic monitoring, or mechanical circulatory support—require cardiac intensive care.

Continuous rhythm monitoring and ready access to defibrillation are appropriate in settings caring for patients with acute infarction and potentially serious arrhythmias. Patients with uncomplicated infarction can often be transferred from intensive care after a period of stability, but the source material does not define a specific transfer protocol for RVI.

Drugs and practical considerations

The supplied material does not provide specific drug doses for RVI.

In critically ill patients with right heart failure, the guideline recommendation supports the use of:

• Inotropes when needed to support cardiac performance

• Vasopressors when required to maintain systemic perfusion

• Fluid management directed at maintaining appropriate preload

• Pulmonary arterial hypertension drugs when appropriate to the underlying clinical situation

The choice and intensity of these treatments should be determined by the haemodynamic state and the underlying cause. No specific agent, dose, sequence, or target is provided for infarct-related right ventricular failure.

Guideline recommendations

The guideline recommendations relevant to right heart failure in intensive care are summarized below.

For suspected RVI, the supplied material supports the following diagnostic approach:

• Obtain an ECG including right-sided precordial leads.

• Use two-dimensional echocardiography to assess right ventricular dysfunction.

• Consider right-heart catheterization when the diagnosis or haemodynamic status remains uncertain, or when precise measurements are required to guide therapy.

• Use volume expansion to maintain adequate right ventricular preload.

• Support left ventricular performance to reduce pulmonary arterial and pulmonary capillary wedge pressures.

Prognosis and follow-up

The prognosis depends on the extent of right ventricular necrosis and the degree of haemodynamic compromise. The clinical range extends from mild dysfunction to cardiogenic shock, indicating substantial variation in short-term risk.

The source material does not provide RVI-specific mortality figures, validated prognostic scores, or a defined outpatient follow-up schedule. Ongoing assessment should therefore be based on recovery of right ventricular function, resolution of systemic venous congestion, restoration of adequate cardiac output, and the need for continuing vasoactive or mechanical support.

When haemodynamic uncertainty persists or symptoms remain severe despite treatment, repeat or follow-up haemodynamic assessment may be clinically useful. More generally, the optimal timing of invasive follow-up assessment has not been established, and routine invasive reassessment has not been shown to produce better outcomes than clinically indicated evaluation.